Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection

Kowdley KV, Sundaram V, Jeon CY, Qureshi K, Latt NL, Sahota A, et al. Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection. Hepatology. 2016;65(4):1094-1103.

Publication Type:

Journal Article

Authors:

Kowdley, KV.; Sundaram, V.; Jeon, CY.; Qureshi, K.; Latt, NL.; Sahota, A.; Lott, S.; M P Curry; Tsai, N.; Chaiyakunapruk, N.; Lee, Y.; Petersen, J.; Buggisch, P.

Source:

Hepatology, Volume 65, Issue 4, p.1094-1103 (2016)

Notes:

PMID: 28027579.

Cited On:

Export Citation:
RIS Format
Top